ACM Research Reports Q3 Revenue of $367.687 Million
Q3 revenue was $367.687 million versus the IBES estimate of $313.2 million.
Related stories
Senstar Technologies Reports Third-Quarter 2026 Financial Results
Senstar reported U.S. market revenue growth of 23%; the headline identifies third-quarter 2026 financial results.
M impact | EQUITY | Nov 06, 2026, 11:48 AM UTC
Lilly to Sell Obesity Drugs Directly on Hims & Hers Site
Eli Lilly struck a deal allowing Hims & Hers Health to sell Zepbound and Foundayo directly on its platform. The drugs were previously available there only if patients left the site
M impact | EQUITY | Nov 06, 2026, 11:47 AM UTC
Gland Pharma Q2 Net Profit Jumps 58.2% to ₹291 Crore
Gland Pharma reported second-quarter FY27 net profit of ₹291 crore, up 58.2% year on year. Revenue rose 23.3% to ₹1,834 crore.
M impact | EQUITY | Nov 06, 2026, 11:46 AM UTC
Moderna Reports Third-Quarter Revenue of $1.31B
M impact | EQUITY | Nov 06, 2026, 11:45 AM UTC
TELUS Reports Third-Quarter 2026 Results
TELUS released unaudited results for the quarter ended September 30, 2026.
M impact | EQUITY | Nov 06, 2026, 11:45 AM UTC
Moderna does not plan to initiate another mRNA-1403 cohort this season
A Phase 3 interim analysis of mRNA-1403 did not meet statistical criteria for early success.
M impact | EQUITY | Nov 06, 2026, 11:45 AM UTC